Biotest sheds U.S. business to allay U.S. concerns of Chinese takeover

FRANKFURT, Jan 19 (Reuters) - Biotest said on Friday that it has sold its U.S. operations, allaying national security concerns by U.S. authorities and paving the way for the German company's sale to a Chinese investor.